{
  "docId": "019dd923-622c-750b-8b97-9fb7a842e09f",
  "docSlug": "cddb6c0b289f",
  "documentTitle": "Eurofins Scientific SE (ERF)",
  "authorId": "51_Muddy_Waters",
  "authorName": "Carson C. Block",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2024-06-24 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 25,
  "pageCount": 36,
  "prevPage": 24,
  "nextPage": 26,
  "slideType": "peer_benchmark",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 16,
  "notes": "The slide highlights financial anomalies in both capital expenditure and M&A strategy.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "bar_chart_grouped",
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b97-9fb7a842e09f/25",
  "deckHref": "/decks/019dd923-622c-750b-8b97-9fb7a842e09f",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b97-9fb7a842e09f.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b97-9fb7a842e09f#slide-25",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Eurofins’ capex as a percentage of revenue is an outlier among its publicly traded peers.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b334-82b4c74bbc26",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.305,
        "w": 0.663,
        "x": 0.168,
        "y": 0.183
      },
      "kind": "chart",
      "text": "Capex to Revenue Ratios, Eurofins and Peers",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "89febd07-810f-47ef-9550-cc571275060c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Capex to Revenue Ratio",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b334-87f4f6f7ed0a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.018,
        "w": 0.675,
        "x": 0.118,
        "y": 0.145
      },
      "kind": "paragraph",
      "text": "Eurofins' capex as a percentage of revenue is an outlier among its publicly traded peers:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b5304e12-8c90-483c-aa63-b1e98b18be5e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.065,
        "w": 0.763,
        "x": 0.118,
        "y": 0.605
      },
      "kind": "paragraph",
      "text": "Eurofins has acquired at least 364 companies since 2014 (see table below).52 In recent years, Eurofins' acquisition disclosure threshold has dropped consistently, indicating that its acquisition sizes are decreasing.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d58ad082-eee6-47ee-99d2-9aeae7f81a41",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.35,
        "x": 0.118,
        "y": 0.853
      },
      "kind": "source-note",
      "text": "52 Eurofins Scientific Annual Report 2014-2023. 53 Eurofins Scientific Annual Report 2020, Pg. 127. 54 Eurofins Scientific Annual Report 2022, Pg. 250. 55 Eurofins Scientific Annual Report 2023, Pg. 265.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "64419344-3c46-4873-88a8-f10a055b0e71",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.763,
        "x": 0.118,
        "y": 0.527
      },
      "kind": "title",
      "text": "Counter-Intuitively, the Larger Eurofins Becomes, the Smaller its Acquisitions Become",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a914ca6-5bfb-4670-bfc3-16918fbdf6a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.022,
        "w": 0.435,
        "x": 0.118,
        "y": 0.096
      },
      "kind": "title",
      "text": "Eurofins' CapEx Again Makes it an Outlier",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cc12d366-9dc5-49e6-a3c8-ea4afd88dd76",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 30,
      "from": 3,
      "beatId": "3d510a0f-6fd9-45d2-879c-09a0eaf3d1a5",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Expose Contradiction",
      "beatSlug": null,
      "evidence": "The research note presents various contradictions in Eurofins Scientific's financial reporting and disclosures.",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}